← Back to Discover
Ishara Investments LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $136,099,277
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ACADIA PHARMACEUTICALS INC · COM · 004225108 · shares: $10,373,000
- XERIS BIOPHARMA HOLDINGS INC · COM · 98422E103 · shares: $9,741,600
- BIOMARIN PHARMACEUTICAL INC · COM · 09061G101 · shares: $8,211,070
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $7,549,515
- ULTRAGENYX PHARMACEUTICAL IN · COM · 90400D108 · shares: $6,844,950
- AGIOS PHARMACEUTICALS INC · COM · 00847X104 · shares: $6,086,040
- INSMED INC · COM PAR $.01 · 457669307 · shares: $5,464,275
- CRINETICS PHARMACEUTICALS IN · COM · 22663K107 · shares: $5,369,770
- ZENTALIS PHARMACEUTICALS INC · COM · 98943L107 · shares: $4,971,250
- VAXCYTE INC · COM · 92243G108 · shares: $4,766,660
Reported holdings
41 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | — | 410,000 shares | $10,373,000 |
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | — | 1,230,000 shares | $9,741,600 |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | — | 143,500 shares | $8,211,070 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 22,550 shares | $7,549,515 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | — | 205,000 shares | $6,844,950 |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | — | 164,000 shares | $6,086,040 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 51,250 shares | $5,464,275 |
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | — | 143,500 shares | $5,369,770 |
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | — | 1,025,000 shares | $4,971,250 |
| VAXCYTE INC | COM | 92243G108 | — | 82,000 shares | $4,766,660 |
| ANNEXON INC | COM | 03589W102 | — | 820,000 shares | $4,682,200 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | — | 82,000 shares | $4,658,420 |
| TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260839 | — | 338,250 shares | $4,316,070 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 57,400 shares | $4,275,152 |
| AXSOME THERAPEUTICS INC. | COM | 05464T104 | — | 16,400 shares | $4,014,228 |
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | — | 205,000 shares | $3,359,950 |
| LEXICON PHARMACEUTICALS INC | COM NEW | 528872302 | — | 1,271,000 shares | $3,050,400 |
| KURA ONCOLOGY INC | COM | 50127T109 | — | 276,750 shares | $3,035,948 |
| DBV TECHNOLOGIES S A | SPONSORED ADS | 23306J309 | — | 184,500 shares | $3,025,800 |
| GENMAB A/S | SPONSORED ADS | 372303206 | — | 102,500 shares | $2,815,675 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 32,800 shares | $2,794,232 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 102,500 shares | $2,765,450 |
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | — | 55,350 shares | $2,434,847 |
| NUVATION BIO INC | COM CL A | 67080N101 | — | 369,000 shares | $2,095,920 |
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | — | 328,000 shares | $1,905,680 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 26,650 shares | $1,860,437 |
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 30,750 shares | $1,691,250 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 32,800 shares | $1,664,600 |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | — | 5,125 shares | $1,542,779 |
| BEAM THERAPEUTICS INC | COM | 07373V105 | — | 41,000 shares | $1,407,120 |
| SIONNA THERAPEUTICS INC | COM | 829401108 | — | 123,000 shares | $1,350,540 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 123,000 shares | $1,332,090 |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | — | 36,900 shares | $1,250,541 |
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | — | 2,460 shares | $1,221,956 |
| ARS PHARMACEUTICALS INC | COM | 82835W108 | — | 143,490 shares | $1,149,355 |
| MONOPAR THERAPEUTICS INC | COM NEW | 61023L207 | — | 12,300 shares | $1,138,857 |
| ERASCA INC | COM | 29479A108 | — | 41,000 shares | $751,120 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 10,250 shares | $439,828 |
| IMMATICS N.V | SHS | N44445109 | — | 30,750 shares | $311,498 |
| MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | — | 768,750 shares | $244,232 |
| GOSSAMER BIO INC | COM | 38341P102 | — | 820,000 shares | $134,972 |